S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying 4 different tipifarnib regimens to compare how
well they work in treating older patients with acute myeloid leukemia. Tipifarnib may stop
the growth of cancer cells by blocking the enzymes necessary for their growth